At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 38 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-Operative Infusion of Low-Dose Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients: A Randomized, Double-Blind, Controlled Pilot Study
In Brief
A Phase 2 clinical trial evaluating Dexmedetomidine and Placebo (Normal Saline) for Post-operative Pain and Respiratory Depression. Completed, enrolled 38 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety, efficacy, hemodynamic and respiratory stability of a low-dose of dexmedetomidine infusion in post-operative surgical in-patients undergoing thoracic surgery after discharge from PACU or ICU.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-operative Pain, Respiratory Depression
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 2006
Enrollment StartMay 2008
Primary CompletionJan 2010
TodayJul 2026
First PostedJun 28, 2006
Enrollment StartMay 1, 2008
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 20.0 years ago
Interventions
Dexmedetomidinedrug
Dexmedetomidine titrated over 24 hours
Placebo (Normal Saline)other